NovoCare Program Eases Patient Access to Ozempic and Wegovy
A guide to using Novo Nordisk's NovoCare program to obtain Ozempic and Wegovy, including eligibility, cost, and verification steps.
Patients prescribed Ozempic or Wegovy have a new pathway to receive their medications through NovoCare, a direct-to-patient service operated by Novo Nordisk. The program is designed to streamline ordering, verify insurance coverage, and reduce out-of-pocket costs for eligible users of the popular GLP-1 drugs.
What NovoCare Offers
NovoCare combines telehealth consultations, prescription delivery, and cost support into a single platform. After a healthcare provider confirms a prescription for Ozempic or Wegovy, patients can register on the NovoCare website or through the companion app. The service then coordinates with the prescribing clinician to verify the order and arranges shipment to the patient's home or a designated pharmacy.
Eligibility and Cost Considerations
Most commercially insured adults qualify for the program, though coverage varies by plan. NovoCare's eligibility tool displays applicable copay amounts before checkout, and the platform also highlights savings options for those without insurance. Patients are advised to confirm that their prescribing provider is in the NovoCare network before proceeding.
Key Steps to Get Started
- Visit the NovoCare website and create a secure account.
- Confirm your prescription for Ozempic or Wegovy with your provider.
- Use the built-in tool to check insurance coverage and estimated copay.
- Place the order and select home delivery or local pharmacy pickup.
For those exploring weight management options, structured routines have helped some users achieve significant results, and public figures like Chrissy Metz have shared updates on their GLP-1 experiences. Patients comparing broader lifestyle strategies may also consider intermittent fasting protocols that some research links to brain health.